JSIGX | VEXRX | JSIGX / VEXRX | |
Total Expense Ratio | 3.12 | 0.33 | 945% |
Annual Report Gross Expense Ratio | 3.92 | 0.33 | 1,188% |
Fund Existence | 13 years | 24 years | - |
Gain YTD | 8.673 | -0.225 | -3,862% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 50000 | 200% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.83M | 20.1B | 0% |
Annual Yield % from dividends | 0.00 | 0.52 | - |
Returns for 1 year | 24.83 | -1.64 | -1,515% |
Returns for 3 years | 42.09 | 20.18 | 209% |
Returns for 5 years | -10.40 | 11.81 | -88% |
Returns for 10 years | 8.20 | 15.36 | 53% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIS | 16.26 | 0.53 | +3.37% |
ProShares UltraShort Nasdaq Biotech | |||
FAPR | 42.37 | N/A | N/A |
FT Vest US Equity Buffer ETF Apr | |||
DFAC | 36.38 | -0.23 | -0.63% |
Dimensional US Core Equity 2 ETF | |||
GINN | 67.45 | -0.68 | -1.00% |
Goldman Sachs Innovate Equity ETF | |||
FLSW | 37.87 | -0.55 | -1.42% |
Franklin FTSE Switzerland ETF |